Cargando…
HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
This discussion paper addresses the safety of HIV cure studies, particularly those involving stopping antiretroviral therapy, known as an analytic treatment interruption (ATI) in the context of the SARS-CoV-2 pandemic. More than 30 studies listed on ClinicalTrials.gov include an ATI and many others...
Autores principales: | Fidler, S., Lewin, S., Deeks, S., Sogaard, O.S., Vanderkerckhove, L., Collins, S., Kelly, D., Singh, J., Caskey, M., Frater, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719279/ https://www.ncbi.nlm.nih.gov/pubmed/33312681 http://dx.doi.org/10.1016/j.jve.2020.100025 |
Ejemplares similares
-
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium
por: Rokx, C., et al.
Publicado: (2021) -
The case for an HIV cure and how to get there
por: Dybul, Mark, et al.
Publicado: (2020) -
Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach
por: Peluso, Michael J, et al.
Publicado: (2020) -
A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption
por: Peluso, Michael J, et al.
Publicado: (2020) -
Maximising the global health impact of future HIV cure-related interventions through advance planning
por: Brown, Regina, et al.
Publicado: (2018)